KLK8 antibody (PB10005) performs well in WB and shows reactivity with Human.

  • Validated for inter-lot consistency, specificity, and reproducibility
  • Committed to quality since 1993
Filter:
pb10005 1 WB anti klk8 kallikrein 8 picoband antibody

Anti-Kallikrein 8/KLK8 Antibody Picoband®

KLK8 antibody

Reactive SpeciesHostApplication
HumanRabbitWB

SKU: PB10005

Size: 100 μg

Bundle to save: I do not want free secondary ab
Price:
$370/100 μg

2 in stock. Ships Next Business Day.

Quantity: 1

1
Get A Quote
Guarantee / Product Promise

Tested Applications

KLK8 antibody was positively detected by WB in:

human placenta tissue

Suggested blocking solution with 5% non-fat milk or BSA; (*)Recommended protein loading: 20-40 ug per lane

Recommend Dilution

Application
Dilution
Species
Western blot
0.1-0.5μg/ml
Human

* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.

Reactive Data

Filter:
Boster Guarantee:What is this?
WB
Human
Tested
Monkey
Predicted

Product Information

Product Name
Anti-Kallikrein 8/KLK8 Antibody Picoband®
View all KLK8 Antibodies
Form
Lyophilized
Uniprot
Gene ID
Storage & Handling
Store at -20˚C for one year from date of receipt. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for six months. Avoid repeated freeze-thaw cycles.
Host
Rabbit
Contents
Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3.
*This antibody is supplied in a stabilized formulation.
Compatibility with conjugation reactions depends on the chemistry of the conjugation method used.
For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.
Clonality
Polyclonal
Isotype
Rabbit IgG
Immunogen
E.coli-derived human Kallikrein 8 recombinant protein (Position: V33-G260). Human Kallikrein 8 shares 74% and 73.1% amino acid (aa) sequence identity with mouse and rat Kallikrein 8, respectively.
Cross-Reactivity
No cross-reactivity with other proteins
Reconstitution
Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Observed Molecular Weight
28 kDa
Calculated Molecular Weight

28.0 kDa

Background of KLK8
Kallikrein-8 is a protein that in humans is encoded by the KLK8 gene. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in tandem in a gene cluster on chromosome 19. The encoded protein may be involved in proteolytic cascade in the skin and may serve as a biomarker for ovarian cancer. Alternate splicing of this gene results in multiple transcript variants encoding different isoforms.
Cite This Product
Anti-Kallikrein 8/KLK8 Antibody Picoband® (Boster Biological Technology, Pleasanton CA, USA, Catalog # PB10005)

Protocols

Western Blot protocol for KLK8 antibody

Review

Have you used Anti-Kallikrein 8/KLK8 Antibody Picoband®?

Submit a review and receive an Amazon gift card.

$30 for a review with an image

Submit A Review

Product Promise

We promise Anti-Kallikrein 8/KLK8 Antibody Picoband® performs excellently in relevant applications for WB. If it doesn't perform as promised, we will refund the product. Learn more

In stock
Order Product
PB10005
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Sep 30, 2026